Establishment of a monoclonal anti‐pan HLA class I antibody suitable for immunostaining of formalin‐fixed tissue: Unusually high frequency of down‐regulation in breast cancer tissues
- 16 March 2012
- journal article
- Published by Wiley in Pathology International
- Vol. 62 (5) , 303-308
Abstract
A novel monoclonal anti‐pan human leukocyte antigen (HLA) class I heavy chain antibody, EMR8‐5, was established. It could detect HLA‐A, ‐B, and ‐C antigens in formalin‐fixed paraffin embedded tissues. By immunohistochemical staining using the EMR8‐5 antibody, various cancer tissues from 246 cases were examined for HLA class I expression. It was found that HLA class I expression was decreased in 20% to 42% of the cases of lung cancer, hepatocellular carcinoma, colon cancer, renal cell carcinoma, and urothelial carcinoma. In contrast, 85% of breast cancer cases had loss of or decreased HLA class I expression. Of the 35 breast cancer cases that had decreased HLA class I heavy chain expression, 33 (94%) also had decreased beta2‐microglobulin expression detected by immunohistochemical staining. It was suggested that HLA class I down‐regulation might be a common characteristic of breast cancer mostly caused by the down‐regulation of beta2‐microglobulin expression.Keywords
This publication has 22 references indexed in Scilit:
- Down-regulation of Human Leukocyte Antigen class I heavy chain in tumors is associated with a poor prognosis in advanced esophageal cancer patientsInternational Journal of Oncology, 2011
- Allele frequency net: a database and online repository for immune gene frequencies in worldwide populationsNucleic Acids Research, 2010
- Analysis and clinical relevance of human leukocyte antigen class I, heavy chain, and β2-microglobulin downregulation in breast cancerHuman Immunology, 2009
- Downregulation of HLA Class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinomaBritish Journal of Cancer, 2008
- Mechanisms of immune evasion of human neuroblastomaCancer Letters, 2005
- Peptide-based vaccination for colorectal cancerExpert Opinion on Biological Therapy, 2005
- Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesionsTissue Antigens, 2005
- Cytotoxicity of Histocompatibility Leukocyte Antigen–DR8–restricted CD4+ Killer T Cells against Human Autologous Squamous Cell CarcinomaJapanese Journal of Cancer Research, 1997
- HLA antigen expression in routinely processed head and neck squamous cell carcinoma primary lesions of different sitesInternational Journal of Cancer, 1991
- HLA-A- and HLA-B-specific monoclonal antibodies reactive with free heavy chains in Western blots, in formalin-fixed, paraffin-embedded tissue sections and in cryo-immuno-electron microscopyInternational Immunology, 1990